Mitochondrial mass assessed by NAO staining in ( a ) HCT116 cells treated with TS-targeting therapies, ( b ) non-small cell lung cancer (NSCLC) cell lines treated with pemetrexed, ( c ) HCT116 cells treated with 5FU, FOLFOX (5FU+oxaliplatin), FOLFIRI (5FU + SN38), or single agent oxaliplatin and SN38, or ( d ) HCT116 cells treated 5FU Torin or rapamycin for 72 h
Opportunity Costs and Alternative Uses of Resources Responsible decision-making also considers opportunity costs - what alternative uses might the resources devoted to injectable glutathione serve
The samples were homogenized to allow for centrifugation of the supernatant, followed by measurement of AngIV, TNF-alpha, IL-10, and IL-1-beta levels through the use of a sensitive and specific ELISA assay
Weeks 4-8: Waist circumference begins to decrease as visceral fat reduces
The agency could accept the recommendation, reject it or request more information